Squarepoint’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
180,298
+86,088
+91% +$770K ﹤0.01% 2257
2025
Q4
$797K Buy
+94,210
New +$672K ﹤0.01% 2808
2025
Q3
Sell
-87,551
Closed -$303K 4950
2025
Q2
$303K Sell
87,551
-27,068
-24% -$80.5K ﹤0.01% 3680
2025
Q1
$300K Sell
114,619
-47,969
-30% -$188K ﹤0.01% 3732
2024
Q4
$670K Buy
162,588
+137,020
+536% +$746K ﹤0.01% 3461
2024
Q3
$181K Sell
25,568
-119,418
-82% -$892K ﹤0.01% 3721
2024
Q2
$945K Buy
+144,986
New +$991K ﹤0.01% 2595
2023
Q4
Sell
-121,544
Closed -$1.02M 4481
2023
Q3
$1.02M Buy
121,544
+91,215
+301% +$981K 0.01% 2301
2023
Q2
$381K Buy
+30,329
New +$377K ﹤0.01% 2812
2023
Q1
Sell
-13,904
Closed -$208K 3753
2022
Q4
$208K Sell
13,904
-25,258
-64% -$483K ﹤0.01% 2767
2022
Q3
$876K Buy
39,162
+3,731
+11% +$81.9K 0.01% 1855
2022
Q2
$593K Buy
35,431
+14,505
+69% +$311K 0.01% 1912
2022
Q1
$626K Buy
+20,926
New +$508K ﹤0.01% 1878
2020
Q4
Sell
-6,212
Closed -$265K 3212
2020
Q3
$265K Buy
+6,212
New +$237K ﹤0.01% 1898

Other funds holding RLAY